Satyavrat Shukla

Satyavrat Shukla

No open positions remaining

Net worth: 99 149 $ as of 31/08/2026

54 year
Health Technology
Consumer Services
Commercial Services

Profile

Satyavrat Shukla worked at Cornerstone Research, Inc. as Principal from 2003 to 2012.
Then worked at Vertex Pharmaceuticals, Inc. as Vice President & Global Head-Corporate Finance from 2012 to 2019.
Worked at Alaunos Therapeutics, Inc. as Chief Financial Officer & Executive Vice President from 2019 to 2020.
Worked at Spero Therapeutics, Inc. as Director in 2025.
Education includes an undergraduate degree from Harvard University in 1993 and an MBA from Yale University in 1999.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2026 81,270 ( 0.14% ) 99 149 $ 31/08/2026

Former positions of Satyavrat Shukla

CompaniesPositionEnd
SPERO THERAPEUTICS, INC. Chief Executive Officer 10/01/2025
ALAUNOS THERAPEUTICS, INC. Director of Finance/CFO 31/12/2020
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/07/2019
Corporate Officer/Principal 01/01/2012
See the detail of Satyavrat Shukla's experience

Training of Satyavrat Shukla

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Satyavrat Shukla